Industry Verticals »

All Categories

Insights »

About TMR »

Hepatitis E Diagnostic Tests Market Forecast Report, 2019-2027

Hepatitis E Diagnostic Tests Market (Test Type - ELISA HEV IgM Test kits, ELISA HEV IgG Test Kits, and RT-PCR Test Kits; End User - Hospitals, Diagnostic Laboratories, Research Centers, and Point of Care) - Global Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast 2019 - 2027

Hepatitis E Diagnostic Tests Market - Snapshot

Hepatitis E is an enteric-transmitted liver disease induced by the hepatitis E virus (HEV). This is one of the five human hepatitis viruses that have been identified (A, B, C, D, and E). Hepatitis E is transmitted via fecal-oral contact due to contamination of drinking water with feces. Vertical transmission from a pregnant woman to her baby, transfusion of contaminated blood products, and eating of undercooked meat and/or meat products produced from infected animals are the additional ways of spread of hepatitis E virus. In areas where sanitation is inadequate, hepatitis E virus infections are widespread, which is likely to benefit development of the global hepatitis e diagnostic tests market in the forthcoming years.

Hepatitis E patients are difficult to identify from other kinds of viral hepatitis. As a result, the detection of RNA and antibodies against HEV can be used to confirm the diagnosis. Indirect tests are the tests conducted to detect the existence of IgG and IgM, while tests for the existence of HEV RNA are called direct tests. The existence of IgM is the primary test for detecting severe infections in patients, which is then validated by RNA testing. If IgG antibodies are present, then the patient has already been infected with the hepatitis E virus.

Rise in the Incidences of Hepatitis E Globally to Drive Growth of the Market

The global hepatitis e diagnostic tests market is being propelled by rising public awareness about the need of early HEV detection. IgG titers in the sample set imply that the person has been infected with HEV earlier. According to the WHO, there are over 20.1 million instances of infection globally, with over 3.3 million of them being symptomatic, resulting in over 70,000 fatalities and 3,000 stillbirths.

In the hepatitis E diagnostic tests market, research institutions and diagnostic laboratories are likely to see significant expansion. The rising sero-prevalence of hepatitis E, which was formerly thought to be a silent illness, has prompted further research into the disease's transmission mechanisms, resulting in the development of research institutions. In addition to that, research is being undertaken on the severe sequelae of hepatitis E, as well as the method of infection of distinct genotypes of hepatitis E, all of which contribute to research institutes' revenue share in the global hepatitis e diagnostic tests market.​​​

  • According to Transparency Market Research’s latest report on the global hepatitis E diagnostic tests market for the historical period 2017–2018 and forecast period 2019–2027, increase awareness among people related to the early diagnosis of hepatitis E, owing to the hyper-endemicity of the disease in certain regions and the growing tourism, leading to the movement of people from hyper-endemic and endemic regions to non-endemic regions are some factors driving the market.
  • According to the report, the global hepatitis E diagnostic tests market was valued at US$ 47.8 Mn in 2018 and is anticipated to expand at a CAGR of 4.5% from 2019 to 2027.

Movement of people from hyper-endemic and endemic regions to non-endemic regions: A Key Driver

  • The growth of hepatitis E diagnostic tests market in Latin America is expected to be modest, owing to the hyper-endemicity of the disease in certain regions and the growing tourism, leading to the movement of people from hyper-endemic and endemic regions to non-endemic regions. For instance, Brazil, Argentina, Peru, and Chile among others are the major tourist destinations in Latin America, attracting tourists from all over the world. In addition, the 2016 Rio Olympics was a major event which attracted major tourists in the region. This has contributed to the movement of tourists to these non-endemic countries in Latin America. Furthermore, hepatitis E is hyper-endemic in Uruguay, Venezuela, Cuba, and Mexico contributing to the growth of hepatitis E diagnostic tests market. In addition, according to WHO/UNICEF Joint Monitoring Programme 2015, more than 106 million people in Latin America live in places without access to proper sanitation. These factors contribute to the spread of hepatitis E, contributing to the growth in the demand for diagnosis, positively leading the growth of hepatitis E diagnostic tests market.

Unfavorable reimbursement policies to Hamper Global Hepatitis E Diagnostic Tests Market

  • Product offering at relatively lower than average selling price has increased market penetration of local players having wide distribution network in certain geographies This is imposing pricing pressure on major manufacturers, thereby intensifying competition. Dominance of local players offering a wide range of reagents portfolio at lower rates is hampering the geographic expansion of major players in particular regions.

Asia Pacific to Account for Major Share of Global Hepatitis E Diagnostic Tests Market

  • Asia Pacific was the dominant region in hepatitis E diagnostic tests market and is expected to remain dominant during the forecast period. Asia Pacific and Middle East and Africa, accounted for a combined market share of more than 60% in 2018. The hyper-endemicity of hepatitis E in various countries of Asia Pacific such as India, Pakistan, Nepal, Bhutan, Bangladesh, Vietnam, Thailand, Kazakhstan, and Burma, among others; and in various countries of Africa, such as Uganda, Kenya, Morocco, and Nigeria, among others contribute to the high revenue share of these regions in hepatitis E diagnostic tests market. North America, and Europe which are the developed regions, do not have significant prevalence of hepatitis E, as this disease is found to be more prevalent in the regions with poor sanitation facilities and with lack of safe drinking water.  In Europe, pork consumption is the highest, indicating the zoonotic mode of transmission of the disease, as swine is considered to be the primary carrier of HEV.

Global Hepatitis E diagnostic tests Market: Competitive Landscape

  • This report profiles major players in the global hepatitis E diagnostic tests market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • Key players operating in the hepatitis E diagnostic tests market include
    • altona Diagnostics GmbH
    • Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
    • Biokit S.A.
    • Dia.Pro - Diagnostic Bioprobes s.r.l, F. Hoffmann-La Roche Ltd.
    • Fast-track diagnostics Ltd.
    • Fortress Diagnostics Limited
    • Mikrogen GmBH
    • MP Biomedicals
    • LLC.
    • Primerdesign Ltd.
    • among others.
  • Several major manufacturers are collaborating, partnering, acquiring emerging market entrants having novel products. This amalgamation of technical expertise of key players and novel product techniques or materials of new players has ensured launch of new products with improved functionalities in the next few years.

Global Hepatitis E Diagnostic Tests Market: Key Developments

Players in the hepatitis E diagnostic tests market are focused on investing in research and development to develop newer devices with enhanced technology which would enable clinicians to perform serological tests for anti-HEV in a single-test format to diagnose the pathology reliably and quickly (40 minutes). This would help the companies to strengthen their market positions.

  • In June 2019, BioMérieux has expanded its hepatitis panel, which already included diagnostic tests for hepatitis A, B and C, with the launch of two VIDAS hepatitis E tests. This will enable the company to strengthen its leadership position in the hepatitis E diagnostic device market.

The report on the global hepatitis E diagnostic tests market discusses individual strategies followed by company profiles of manufacturers of hepatitis E diagnostic tests treatment products. The competitive landscape section has been included in the hepatitis E diagnostic tests market report to provide readers with a dashboard view and a company hepatitis E diagnostic tests market share analysis of key players operating in the global Hepatitis E diagnostic tests market.

Global Hepatitis E Diagnostic Tests Market - Segmentation

Test Type
  • ELISA HEV IgM Test kits
  • ELISA HEV IgG Test kits
  • RT-PCR Test kits
  • Others

End-user
  • Hospitals
  • Research Centers
  • Diagnostic Laboratories
  • Point of Care

Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Frequently Asked Questions

What is the total market worth of hepatitis E diagnostic tests market?

Hepatitis E diagnostic tests market was valued at US$ 47.8 Mn in 2018 and to reach US$ 67.9 Mn By 2027

What is the anticipated CAGR of the hepatitis E diagnostic tests market in the forecast period?

Hepatitis E diagnostic tests market is projected to expand at a CAGR of 4.5% from 2019 to 2027

What are the key driving factors for the growth of the hepatitis E diagnostic tests market?

Hepatitis E diagnostic tests market is driven by increase awareness among people related to the early diagnosis of HEV

Which region is expected to project the highest market share in the global hepatitis E diagnostic tests market?

Asia Pacific held the largest share of the global hepatitis E diagnostic tests market, and this region is expected to remain dominant during the forecast period

Who are the key players in the global hepatitis E diagnostic tests market?

Key players in the hepatitis E diagnostic tests market include altona Diagnostics GmbH, Beijing Wantai Biological Pharmacy Enterprise Co., Ltd., Biokit S.A., Dia.Pro - Diagnostic Bioprobes s.r.l, F. Hoffmann-La Roche Ltd., Fast-track diagnostics Ltd

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Hepatitis E Diagnostic Tests Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Type Definition

            4.1.2. Industry Evolution / Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Hepatitis E Diagnostic Tests Market Analysis and Forecast, 2018–2030

            4.4.1. Market Revenue Projections (US$ Mn)

        4.5. Porter’s Five Force Analysis

    5. Key Insights

        5.1. Value Chain Analysis

        5.2. Disease Overview

        5.3. Regulatory approval process

    6. Global Hepatitis E Diagnostic Tests Market Analysis and Forecast, by Test Type

        6.1. Introduction & Definition

            6.1.1. Key Findings / Developments

        6.2. Global Hepatitis E Diagnostic Tests Market Value Forecast, by Test Type, 2018–2030

            6.2.1. HEV IgM ELISA Test kits

            6.2.2. HEV IgG ELISA Test kits

            6.2.3. RT-PCR Test kits

            6.2.4. Others

        6.3. Global Hepatitis E Diagnostic Tests Market Attractiveness, by Test Type  

    7. Global Hepatitis E Diagnostic Tests Market Analysis and Forecast, by End User

        7.1. Introduction & Definition

            7.1.1. Key Findings / Developments

        7.2. Global Hepatitis E Diagnostic Tests Market Value Forecast, by End User, 2018–2030

            7.2.1. Hospitals

            7.2.2. Diagnostic Laboratories

            7.2.3. Research Centers

            7.2.4. Point of Care

        7.3. Global Hepatitis E Diagnostic Tests Market Attractiveness, by End User

    8. Global Hepatitis E Diagnostic Tests Market Analysis and Forecast, by Region

        8.1. Key Findings

        8.2. Global Hepatitis E Diagnostic Tests Market Value Forecast, by Region

            8.2.1. North America

            8.2.2. Europe

            8.2.3. Asia Pacific

            8.2.4. Latin America

            8.2.5. Middle East & Africa

        8.3. North America Hepatitis E Diagnostic Tests Market Attractiveness, by Region

    9. North America Hepatitis E Diagnostic Tests Market Analysis and Forecast

        9.1. Introduction

            9.1.1. Key Findings

        9.2. North America Hepatitis E Diagnostic Tests Market Value (US$ Mn) Forecast, by Test Type, 2018–2030

            9.2.1. HEV IgM ELISA Test kits

            9.2.2. HEV IgG ELISA Test kits

            9.2.3. RT-PCR Test kits

            9.2.4. Others

        9.3. North America Hepatitis E Diagnostic Tests Market Value (US$ Mn) Forecast, by End User, 2018–2030

            9.3.1. Hospitals

            9.3.2. Diagnostic Laboratories

            9.3.3. Research Centers

            9.3.4. Point of Care

        9.4. North America Hepatitis E Diagnostic Tests Market Value (US$ Mn) Forecast, by Country, 2018–2030

            9.4.1. U.S.

            9.4.2. Canada

        9.5. North America Hepatitis E Diagnostic Tests Market Attractiveness Analysis

            9.5.1. By Test Type

            9.5.2. By End User

            9.5.3. By Country

    10. Europe Hepatitis E Diagnostic Tests Market Analysis and Forecast

        10.1. Europe Hepatitis E Diagnostic Tests Market Value (US$ Mn) Forecast, by Test Type, 2018–2030

            10.1.1. HEV IgM ELISA Test kits

            10.1.2. HEV IgG ELISA Test kits

            10.1.3. RT-PCR Test kits

            10.1.4. Others  

        10.2. Europe Hepatitis E Diagnostic Tests Market Value (US$ Mn) Forecast, by End User, 2018–2030

            10.2.1. Hospitals

            10.2.2. Diagnostic Laboratories

            10.2.3. Research Centers

            10.2.4. Point of Care

        10.3. Europe Hepatitis E Diagnostic Tests Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

            10.3.1. Germany

            10.3.2. U.K.

            10.3.3. France

            10.3.4. Spain

            10.3.5. Italy

            10.3.6. Rest of Europe

        10.4. Europe Hepatitis E Diagnostic Tests Market Attractiveness Analysis

            10.4.1. By Test Type

            10.4.2. By End User

            10.4.3. By Country/Sub-region

    11. Asia Pacific Hepatitis E Diagnostic Tests Market Analysis and Forecast

        11.1. Asia Pacific Hepatitis E Diagnostic Tests Market Value (US$ Mn) Forecast, by Test Type, 2018–2030

            11.1.1. HEV IgM ELISA Test kits

            11.1.2. HEV IgG ELISA Test kits

            11.1.3. RT-PCR Test kits

            11.1.4. Others  

        11.2. Asia Pacific Hepatitis E Diagnostic Tests Market Value (US$ Mn) Forecast, by End User, 2018–2030

            11.2.1. Hospitals

            11.2.2. Diagnostic Laboratories

            11.2.3. Research Centers

            11.2.4. Point of Care

        11.3. Asia Pacific Hepatitis E Diagnostic Tests Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

            11.3.1. China

            11.3.2. Japan

            11.3.3. India

            11.3.4. Australia & New Zealand

            11.3.5. Rest of Asia Pacific

        11.4. Asia Pacific Hepatitis E Diagnostic Tests Market Attractiveness Analysis

            11.4.1. By Test Type

            11.4.2. By End User

            11.4.3. By Country/Sub-region

    12. Latin America Hepatitis E Diagnostic Tests Market Analysis and Forecast

        12.1. Latin America Hepatitis E Diagnostic Tests Market Value (US$ Mn) Forecast, by Test Type, 2018–2030

            12.1.1. HEV IgM ELISA Test kits

            12.1.2. HEV IgG ELISA Test kits

            12.1.3. RT-PCR Test kits

            12.1.4. Others

        12.2. Latin America Hepatitis E Diagnostic Tests Market Value (US$ Mn) Forecast, by End User, 2018–2030

            12.2.1. Hospitals

            12.2.2. Diagnostic Laboratories

            12.2.3. Research Centers

            12.2.4. Point of Care

        12.3. Latin America Hepatitis E Diagnostic Tests Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

            12.3.1. Brazil

            12.3.2. Mexico

            12.3.3. Rest of Latin America Latin America

        12.4. Latin America Hepatitis E Diagnostic Tests Market Attractiveness Analysis

            12.4.1. By Test Type

            12.4.2. By End User

            12.4.3. By Country/Sub-region

    13. Middle East & Africa Hepatitis E Diagnostic Tests Market Analysis and Forecast

            13.1.1.  

        13.2. Middle East & Africa Hepatitis E Diagnostic Tests Market Value (US$ Mn) Forecast, by Test Type, 2018–2030

            13.2.1. HEV IgM ELISA Test kits

            13.2.2. HEV IgG ELISA Test kits

            13.2.3. RT-PCR Test kits

            13.2.4. Others

        13.3. Middle East & Africa Hepatitis E Diagnostic Tests Market Value (US$ Mn) Forecast, by End User, 2018–2030

            13.3.1. Hospitals

            13.3.2. Diagnostic Laboratories

            13.3.3. Research Centers

            13.3.4. Point of Care

        13.4. Middle East & Africa Hepatitis E Diagnostic Tests Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

            13.4.1. GCC Countries

            13.4.2. South Africa

            13.4.3. Rest of Middle East & Africa

        13.5. Middle East & Africa Hepatitis E Diagnostic Tests Market Attractiveness Analysis

            13.5.1. By Test Type

            13.5.2. By End User

            13.5.3. By Country/Sub-region

    14. Competition Landscape

        14.1. Market Player - Competition Matrix (by Tier and Size of companies)

        14.2. Market Share / Position Analysis, by Company (2018)

        14.3. Competitive Business Strategies

        14.4. Company Profiles

            14.4.1. altona Diagnostics GmbH

                14.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.1.2. Growth Strategies

                14.4.1.3. SWOT Analysis

            14.4.2. Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

                14.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.2.2. Growth Strategies

                14.4.2.3. SWOT Analysis

            14.4.3. Biokit S.A.

                14.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.3.2. Growth Strategies

                14.4.3.3. SWOT Analysis

            14.4.4. Dia.Pro - Diagnostic Bioprobes s.r.l

                14.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.4.2. Growth Strategies

                14.4.4.3. SWOT Analysis

            14.4.5. F. Hoffmann-La Roche Ltd.

                14.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.5.2. Growth Strategies

                14.4.5.3. SWOT Analysis

            14.4.6. Fast-track diagnostics Ltd.

                14.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.6.2. Growth Strategies

                14.4.6.3. SWOT Analysis

            14.4.7. Fortress Diagnostics Limited

                14.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.7.2. Growth Strategies

                14.4.7.3. SWOT Analysis

            14.4.8. Mikrogen GmBH

                14.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.8.2. Growth Strategies

                14.4.8.3. SWOT Analysis

            14.4.9. MP Biomedicals, LLC.

                14.4.9.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.9.2. Growth Strategies

                14.4.9.3. SWOT Analysis

            14.4.10. Primerdesign Ltd.

                14.4.10.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.10.2. Growth Strategies

                14.4.10.3. SWOT Analysis

    List of Tables

    Table 01: Global Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by Test Type, 2016–2024

    Table 02: Global Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by End-user, 2016–2024

    Table 03: Global Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by Region, 2016–2024

    Table 04: North America Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by Test Type, 2016–2024

    Table 05: North America Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by End-User, 2016–2024

    Table 06: North America Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by Country, 2016–2024

    Table 07: Europe Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by Test Type, 2016–2024

    Table 08: Europe Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by End-user, 2016–2024

    Table 09: Europe Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by Country, 2016–2024

    Table 10: Asia Pacific Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by Test Type, 2016–2024

    Table 11: Asia Pacific Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by End-user, 2016–2024

    Table 12: Asia Pacific Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by Country, 2016–2024

    Table 13: Latin America Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by Test Type, 2016–2024

    Table 14: Latin America Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by End-User, 2016–2024

    Table 15: Latin America Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by Country, 2016–2024

    Table 16: Middle East & Africa Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by Test Type, 2016–2024

    Table 17: Middle East & Africa Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by End-User, 2016–2024

    Table 18: Middle East & Africa Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by Country, 2016–2024

    List of Figures

    Figure 1: Global Hepatitis E Diagnostic Tests Market Size (US$ Mn) and Forecast, 2016–2024

    Figure 02: Global Market Value Share, by Test Type (2016)

    Figure 03: Global Market Value Share, by End-user (2016)

    Figure 04: Global Market Value Share, by Region (2016)

    Figure 05: Global Hepatitis E Diagnostic Tests Market Value Share Analysis, by Test Type, 2015 and 2024

    Figure 06: Global ELISA HEV IgM Test kits Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2024

    Figure 07: Global ELISA HEV IgG Test kits Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2024

    Figure 08: Global ELISA RT-PCR Test kits Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2024

    Figure 09: Global Others Test kits Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2024

    Figure 10: Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by Test Type, 2015

    Figure 11: Global Hepatitis E Diagnostic Tests Market Value Share Analysis, by End-user, 2015 and 2024

    Figure 12: Global Hospitals Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2024

    Figure 13: Global Diagnostic Laboratories Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2024

    Figure 14: Global Research Centers Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2024

    Figure 15: Global Point of Care Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2024

    Figure 16: Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by End-user, 2015

    Figure 17: Global Hepatitis E Diagnostic Tests Market Revenue, US$ Mn, 2014–2024

    Figure 18: Global Hepatitis E Diagnostic Tests Market Value Share Analysis, by Region, 2015 and 2024

    Figure 19: Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by Region, 2015

    Figure 20: North America Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, 2014–2024

    Figure 21: North America Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by Country, 2015

    Figure 22: North America Hepatitis E Diagnostic Tests Market Value Share Analysis, by Test Type, 2015 and 2024

    Figure 23: North America Hepatitis E Diagnostic Tests Market Value Share Analysis, by End-User, 2015 and 2024

    Figure 24: North America Hepatitis E Diagnostic Tests Market Value Share Analysis, by Country, 2015 and 2024

    Figure 25: North America Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by Test Type, 2015

    Figure 26: North America Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by End-User, 2015

    Figure 27: Europe Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, 2014–2024

    Figure 28: Europe Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by Country, 2015

    Figure 29: Europe Hepatitis E Diagnostic Tests Market Value Share Analysis, by Test Type, 2015 and 2024

    Figure 30: Europe Hepatitis E Diagnostic Tests Market Value Share Analysis, by End-user, 2015 and 2024

    Figure 31: Europe Hepatitis E Diagnostic Tests Market Value Share Analysis, by Country, 2015 and 2024

    Figure 32: Europe Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by Test Type, 2015

    Figure 33: Europe Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by End-user, 2015

    Figure 34: Asia Pacific Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, 2014–2024

    Figure 35: Asia Pacific Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by Country, 2015

    Figure 36: Asia Pacific Hepatitis E Diagnostic Tests Market Value Share Analysis, by Test Type, 2015 and 2024

    Figure 37: Asia Pacific Hepatitis E Diagnostic Tests Market Value Share Analysis, by End-user, 2015 and 2024

    Figure 38: Asia Pacific Hepatitis E Diagnostic Tests Market Value Share Analysis, by Country, 2015 and 2024

    Figure 39: Asia Pacific Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by Test Type, 2015

    Figure 40: Asia Pacific Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by End-user, 2015

    Figure 41: Latin America Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, 2014–2024

    Figure 42: Latin America Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by Country, 2015

    Figure 43: Latin America Hepatitis E Diagnostic Tests Market Value Share Analysis, by Test Type, 2015 and 2024

    Figure 44: Latin America Hepatitis E Diagnostic Tests Market Value Share Analysis, by End-User, 2015 and 2024

    Figure 45: Latin America Hepatitis E Diagnostic Tests Market Value Share Analysis, by Country, 2015 and 2024

    Figure 46: Latin America Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by Test Type, 2015

    Figure 47: Latin America Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by End-User, 2015

    Figure 48: Middle East & Africa Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, 2014–2024

    Figure 49: Middle East & Africa Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by Country, 2015

    Figure 50: Middle East & Africa Hepatitis E Diagnostic Tests Market Value Share Analysis, by Test Type, 2015 and 2024

    Figure 51: Middle East & Africa Hepatitis E Diagnostic Tests Market Value Share Analysis, by End-User, 2015 and 2024

    Figure 52: Middle East & Africa Hepatitis E Diagnostic Tests Market Value Share Analysis, by Country, 2015 and 2024

    Figure 53: Middle East & Africa Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by Test Type, 2015

    Figure 54: Middle East & Africa Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by End-User, 2015

    Figure 55: Global Hepatitis E Diagnostic Tests Market Share Analysis, by Company

Copyright © Transparency Market Research, Inc. All Rights reserved

Hepatitis E Diagnostic Tests Market Forecast Report, 2019-2027

Schedule a Call